Social Norms Shift, But US Rules On Cannabis-Related Drug R&D Lag Behind
This article was originally published in Start Up
Executive Summary
While public, regulatory, and law enforcement attitudes toward marijuana in the US continue to shift, it's still tough to pursue legitimate clinical research on cannabis and cannabinoids. Could the exceptions slowly become the rule?